
Analyses showed that times to first revascularization events were significantly reduced by icosapent ethyl vs placebo across subtypes of intervention.

Analyses showed that times to first revascularization events were significantly reduced by icosapent ethyl vs placebo across subtypes of intervention.

Authors of a new study found no association between treatment with high blood pressure drugs and an increased risk of contracting novel COVID-19.

The SGLT-2 inhibitor is the first in its class to be approved for the treatment of adults with NYHA class II, III, or IV heart failure with reduced (≤40%) ejection fraction.

A newly published study found that Pilates may be effective in improving cardiovascular health for obese young women.

The case fatality rate for patients with COVID-19 and CVD is higher than for cancer, chronic respiratory disease, and diabetes. Here is current guidance from the ACC.

A new joint statement from the AHA, HFSA, and ACC urge physicians to continue treatment with ACE-i or ARBs in patients with COVID-19.

Global leaders in obesity research plus hundreds of medical, scientific, & academic associations and institutions have taken this pledge to end the stigma.

Antihypertension drugs deliver similar reduction in CV events, a new study finds. Message: Focus on reaching target BP, not on drug class.

More than 50% of patients with obesity say weight loss is a priority for them. What percentage of their physicians feel the same? #ObesityCareWeek

The 2019 ACC/AHA guidelines on the primary prevention of cardiovascular disease could change your clinical practice. Try these 9 questions to find out how.

Irregular sleep patterns in women may impact quality of diet and calories consumed, increasing risk for cardiometabolic disease, concludes a new study.

Drinking 12 oz/day of sugary drinks a day can lower good cholesterol levels and increase triglyceride levels, according to a new prospective study.

Liraglutide added to intensive behavior therapy in primary care practice significantly improved weight loss vs behavior therapy alone, a new study found.

Based on results from REWIND, dulaglutide is the first GLP-1 receptor agonist to be approved for both primary and secondary CV prevention in type 2 diabetes.

Weight Watchers (WW), Jenny Craig, and the Nutrarian Diet top the list of 10 best brand-name diet plans. Get highlights here, then find out what your patients are reading.

Help your patients stay active and heart-healthy for American Heart Month with these top 5 cardio apps.

Americans are living longer but not healthier, prompting the American Heart Association to release ambitious 2030 Impact Goals.

To help primary care physicians focus on details essential to optimal BP control, we summarize checklists from Target: BP, a new AHA/AMA initiative.

Of 35 of the most popular diets ranked by health experts, we highlight the top 10. The "Best Diets" issue reached your patients this month. See what they're reading.

A new review found >2 million US adults with heart disease have either used marijuana in the past or are current users.

Abdominal obesity was independently associated with recurrent MI or stroke despite secondary preventive measures, according to a new study.

The novel test was shown to be effective in the early detection of symptom-free patients with coronary artery disease.

Cardiovascular diseases, particularly heart failure, were found significantly and independently associated with end-stage renal disease in a new analysis.

Dyslipidemia guidelines from the US and Europe take slightly different routes to similar ends. Test your knowledge of the twists and turns.

A new study found a significant association between increased stroke risk and dual use of e-cigarettes and traditional cigarettes-authors urging physicians to use results as a wake-up call.